291 related articles for article (PubMed ID: 22675625)
1. The current state of targeted agents in rectal cancer.
Kim DD; Eng C
Int J Surg Oncol; 2012; 2012():406830. PubMed ID: 22675625
[TBL] [Abstract][Full Text] [Related]
2. The role of targeted agents in preoperative chemoradiation for rectal cancer.
Wadlow RC; Ryan DP
Cancer; 2010 Aug; 116(15):3537-48. PubMed ID: 20564106
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapeutic agents for colorectal cancer.
Chee CE; Sinicrope FA
Gastroenterol Clin North Am; 2010 Sep; 39(3):601-13. PubMed ID: 20951919
[TBL] [Abstract][Full Text] [Related]
4. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
5. Biologics in rectal cancer.
Jácome AA; Peixoto RD; Gil MV; Ominelli J; Prolla G; Dienstmann R; Eng C
Expert Opin Biol Ther; 2022 Oct; 22(10):1245-1257. PubMed ID: 35912589
[TBL] [Abstract][Full Text] [Related]
6. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
7. Medical treatment of advanced colorectal cancer in 2009.
Grothey A
Ther Adv Med Oncol; 2009 Sep; 1(2):55-68. PubMed ID: 21789113
[TBL] [Abstract][Full Text] [Related]
8. Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments.
Tang YL; Li DD; Duan JY; Sheng LM; Wang X
World J Gastroenterol; 2023 Feb; 29(6):926-948. PubMed ID: 36844139
[TBL] [Abstract][Full Text] [Related]
9. Integration of biologic agents with cytotoxic chemotherapy in metastatic colorectal cancer.
Jain VK; Hawkes EA; Cunningham D
Clin Colorectal Cancer; 2011 Dec; 10(4):245-57. PubMed ID: 21729675
[TBL] [Abstract][Full Text] [Related]
10. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
[TBL] [Abstract][Full Text] [Related]
11. Targeted therapies as adjuvant treatment for early-stage colorectal cancer: first impressions and clinical questions.
Banerjee S; Cunningham D
Clin Colorectal Cancer; 2010 Jun; 9 Suppl 1():S28-35. PubMed ID: 20630848
[TBL] [Abstract][Full Text] [Related]
12. Genetics of rectal cancer and novel therapies: primer for radiologists.
Mondaca S; Yaeger R
Abdom Radiol (NY); 2019 Nov; 44(11):3743-3750. PubMed ID: 31073721
[TBL] [Abstract][Full Text] [Related]
13. Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review.
Arbour KC; Riely GJ
JAMA; 2019 Aug; 322(8):764-774. PubMed ID: 31454018
[TBL] [Abstract][Full Text] [Related]
14. From Molecular Biology to Clinical Trials: Toward Personalized Colorectal Cancer Therapy.
Palma S; Zwenger AO; Croce MV; Abba MC; Lacunza E
Clin Colorectal Cancer; 2016 Jun; 15(2):104-15. PubMed ID: 26777471
[TBL] [Abstract][Full Text] [Related]
15. Advances in targeted and immunobased therapies for colorectal cancer in the genomic era.
Seow HF; Yip WK; Fifis T
Onco Targets Ther; 2016; 9():1899-920. PubMed ID: 27099521
[TBL] [Abstract][Full Text] [Related]
16. Molecular predictors of response to chemotherapy in colorectal cancer.
Dienstmann R; Vilar E; Tabernero J
Cancer J; 2011; 17(2):114-26. PubMed ID: 21427555
[TBL] [Abstract][Full Text] [Related]
17. Genomic diversity of colorectal cancer: Changing landscape and emerging targets.
Ahn DH; Ciombor KK; Mikhail S; Bekaii-Saab T
World J Gastroenterol; 2016 Jul; 22(25):5668-77. PubMed ID: 27433082
[TBL] [Abstract][Full Text] [Related]
18. Delivery of Personalized Care for Locally Advanced Rectal Cancer: Incorporating Pathological, Molecular Genetic, and Immunological Biomarkers Into the Multimodal Paradigm.
Ryan ÉJ; Creavin B; Sheahan K
Front Oncol; 2020; 10():1369. PubMed ID: 32923389
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomic-Guided Therapy in Colorectal Cancer.
Diasio RB; Innocenti F; Offer SM
Clin Pharmacol Ther; 2021 Sep; 110(3):616-625. PubMed ID: 34114648
[TBL] [Abstract][Full Text] [Related]
20. Molecular Testing for the Treatment of Advanced Colorectal Cancer: An Overview.
Lin PS; Semrad TJ
Methods Mol Biol; 2018; 1765():281-297. PubMed ID: 29589315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
